Türkiye health technology: industrial scale and public procurement signals require a product-, registration- and buyer-specific route

Verified facts

• Türkiye’s Ministry of Health reported at a May 2026 medical-device governance summit that local production represented more than 31% of public medical-device procurement and that the national product-tracking system covered approximately 5.3 million devices. Ministerial figures describe the policy and operating environment; they do not constitute registration, reimbursement, procurement eligibility, a distributor appointment or buyer demand for a particular product.
• The Ministry’s health-technology-assessment unit reported in June 2026 that revision work on the National Health Technology Assessment Strategy had begun. A strategy revision workshop is not a coverage decision, a reimbursement pathway, a product evaluation or a commercial invitation.
• A Ministry of Health guidance page published in June 2026 refers to medical-device registration processes in the product-tracking system. A process guide does not resolve the classification, authorised representative, conformity assessment, clinical evidence, labelling, vigilance, establishment registration or post-market duties for a defined device or software claim.
• A Ministry of Health 2026 request for expressions of interest for an infectious-disease surveillance and early-warning software assignment specifies a World Bank-financed consulting procurement with a 7 September 2026 deadline. It is a historically specific procurement example; it must not be presented as a live call, a general health-data access route or a precedent that grants eligibility for other work.
• WHO’s operational review of Türkiye provides independent context on the country’s digital-health infrastructure and chronic-disease response. System-level context cannot establish a lawful data pathway, integration permission, health-provider contract, security clearance or commercial need for an external product.
• WHO’s medical-device material distinguishes product categories and highlights the importance of appropriate regulation, technical specifications and procurement. It is a global reference framework, not Turkish market authorisation or a substitute for device-specific regulatory analysis.